Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -255.73%-48.22K | -379.79%-36.58K | -6,284.00%-15.96K | 21.00%-42.22K | -26.06%-20.79K | 50.76%-13.55K | -7.63K | 97.35%-250 | 86.30%-53.44K | 96.71%-16.49K |
| Net income from continuing operations | -200.12%-51.49K | -297.24%-78.87K | -206.22%-70.56K | -39.51%-110.9K | -105.65%-50.85K | 51.10%-17.16K | ---19.85K | -17.07%-23.04K | 79.76%-79.49K | 93.33%-24.72K |
| Remuneration paid in stock | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Change In working capital | -9.05%3.28K | 245.78%42.29K | 139.55%54.6K | 163.59%68.68K | 265.06%30.06K | -52.32%3.6K | --12.23K | 122.03%22.79K | 838.95%26.06K | 106.27%8.23K |
| -Change in receivables | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| -Change in prepaid assets | 424.42%4.19K | -819.13%-9.13K | -286.63%-1.45K | -2,265.12%-1.02K | 43.21%-623 | -162.59%-1.29K | --1.27K | 62.86%-374 | -101.33%-43 | -107.99%-1.1K |
| -Change in payables and accrued expense | -118.56%-908 | 369.19%51.42K | 141.93%56.04K | 167.06%69.7K | 228.82%30.68K | -10.97%4.89K | --10.96K | 105.51%23.17K | 5,886.92%26.1K | -62.67%9.33K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -255.73%-48.22K | -379.79%-36.58K | -6,284.00%-15.96K | 21.00%-42.22K | -26.06%-20.79K | 50.76%-13.55K | ---7.63K | 97.35%-250 | 86.30%-53.44K | 96.71%-16.49K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 204K | 204K | 0 | 0 | |||||
| Net common stock issuance | --0 | ---- | ---- | --204K | --204K | --0 | ---- | ---- | --0 | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | ---- | ---- | --204K | --204K | --0 | ---- | ---- | --0 | ---- |
| Net cash flow | ||||||||||
| Beginning cash position | 1,051.63%231.19K | 527.34%173.77K | 578.83%189.73K | -65.66%27.95K | -85.33%6.52K | -92.08%20.08K | -89.07%27.7K | -90.73%27.95K | -73.00%81.39K | -82.46%44.44K |
| Current changes in cash | -255.73%-48.22K | 853.00%57.42K | -6,284.00%-15.96K | 402.77%161.78K | 1,211.06%183.21K | -221.65%-13.55K | ---7.63K | 99.48%-250 | 75.72%-53.44K | 90.41%-16.49K |
| End cash Position | 2,705.93%182.98K | 1,051.63%231.19K | 527.34%173.77K | 578.83%189.73K | 578.83%189.73K | -85.33%6.52K | -92.08%20.08K | -89.07%27.7K | -65.66%27.95K | -65.66%27.95K |
| Free cash from | -255.73%-48.22K | -379.79%-36.58K | -6,284.00%-15.96K | 21.00%-42.22K | -26.06%-20.79K | 50.76%-13.55K | ---7.63K | 97.35%-250 | 86.30%-53.44K | 95.18%-16.49K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.